Resmed (RMD) Asset Writedowns and Impairment (2009 - 2021)

Resmed's Asset Writedowns and Impairment history runs 11 years deep, the most recent figure standing at -$5.1 million for Q2 2021.

• Quarterly Asset Writedowns and Impairment changed N/A year-over-year to -$5.1 million in Q2 2021, while the trailing twelve-month figure through Jun 2021 was -$14.5 million (down 199.97% YoY) and the FY2023 annual result came in at -$9.9 million, down 181.31% from the prior year.
• Asset Writedowns and Impairment was -$5.1 million for Q2 2021 at Resmed, down from -$4.7 million in the prior quarter.
• Across five years, Asset Writedowns and Impairment topped out at $9.1 million in Q1 2020 and bottomed at -$8.5 million in Q3 2020.
• A 5-year average of $1.7 million and a median of $1.4 million in 2017 frame the typical range for Asset Writedowns and Impairment.
• Annual changes were most pronounced in 2018 — Asset Writedowns and Impairment soared 483.25% — and 2020, when it sank 426.0%.
• Resmed's Asset Writedowns and Impairment stood at $1.3 million in 2017, then declined by 3.41% to $1.2 million in 2018, then soared by 125.88% to $2.8 million in 2019, then jumped by 31.25% to $3.7 million in 2020, then plunged by 237.11% to -$5.1 million in 2021.
• Business Quant data shows RMD's Asset Writedowns and Impairment at -$5.1 million in Q2 2021, -$4.7 million in Q1 2021, and $3.7 million in Q4 2020.